IUHSA
NTGN

Itau Unibanco Holding S.A.’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-335
Closed -$2K – 1024
2019
Q3 		$2K Buy
+335
New +$1.02K ﹤0.01% 298

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Itau Unibanco Holding S.A.'s NTGN Position: Q3 2019 in Review

Itau Unibanco Holding S.A. sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q3 2019, closing a stake of 335 shares — an estimated $1.02K sold.

Itau Unibanco Holding S.A. first reported a position in NTGN in Q2 2018 and held it in 5 quarters. The position peaked at $3K in Q2 2018. 58 funds tracked by Wall St. Rank hold NTGN as of Q3 2019.

  • Itau Unibanco Holding S.A. reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 335 Neon Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $1.02K.
  • Itau Unibanco Holding S.A. first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • Itau Unibanco Holding S.A.'s Neon Therapeutics, Inc. Common Stock position peaked at $3K in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2019, filed 14 Nov 2019.